Literature DB >> 6132643

Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices.

A M Galzin, S Z Langer.   

Abstract

1 Rabbit hypothalamic slices prelabelled with [3H]-noradrenaline and superfused with Krebs solution were stimulated electrically at a frequency of 5 Hz. Exposure to verapamil (0.1 to 10 microM) significantly increased, in a concentration-dependent manner, the electrically-evoked overflow of tritium, without affecting the spontaneous outflow of radioactivity. 2 Exposure to diltiazem in concentrations up to 100 microM had no effect on the electrically evoked release of [3H]-noradrenaline, but increased the basal outflow of radioactivity at 10 and 100 microM. 3 The preferential alpha 2-adrenoceptor antagonist, yohimbine (0.1 microM) significantly antagonized the inhibitory effect of clonidine or adrenaline on [3H]-noradrenaline overflow elicited by electrical stimulation. Verapamil (3 microM) also antagonized this inhibitory effect of the alpha 2-adrenoceptor agonists on [3H]-noradrenaline release. In contrast to these results, exposure to diltiazem (10 microM) was ineffective in blocking the action of the alpha 2-adrenoceptor agonist. 4 These results suggest that the two Ca2+-antagonists verapamil and diltiazem differ in their ability to affect central noradrenergic neurotransmission. While verapamil is a relatively potent alpha 2-adrenoceptor antagonist, diltiazem is devoid of presynaptic alpha 2-adrenoceptor antagonist properties.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132643      PMCID: PMC2044725          DOI: 10.1111/j.1476-5381.1983.tb08817.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

Review 1.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 2.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

3.  Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals.

Authors:  G Haeusler
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

4.  Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts.

Authors:  M Göthert; P Nawroth; H Neumeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

5.  The effects of some organic "calcium antagonists" on calcium influx in presynaptic nerve terminals.

Authors:  D A Nachshen; M P Blaustein
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

6.  The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors.

Authors:  W G Nayler; J E Thompson; B Jarrott
Journal:  J Mol Cell Cardiol       Date:  1982-03       Impact factor: 5.000

7.  Alpha-drenergic inhibition of calcium-dependent potentials in rat sympathetic neurones.

Authors:  J P Horn; D A McAfee
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

Review 8.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

9.  Potassium-induced release of [3H] GABA and of [3H] noradrenaline from normal and reserpinized rat brain cortex slices, Differences in calcium-dependency, and in sensitivity to potassium ions.

Authors:  O Vargas; M D de Lorenzo; M C Saldate; F Orrego
Journal:  J Neurochem       Date:  1977-01       Impact factor: 5.372

10.  Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices.

Authors:  F Pelayo; M L Dubocovich; S Z Langer
Journal:  Eur J Pharmacol       Date:  1980-06-13       Impact factor: 4.432

View more
  12 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Preferential antagonism by diltiazem of alpha 2-adrenoceptor mediated vasoconstrictor responses in perfused tail arteries of spontaneous hypertensive rats.

Authors:  P E Hicks; C Tierney; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

3.  Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.

Authors:  F Bongianni; V Carla; F Moroni; D E Pellegrini-Giampietro
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

4.  Attenuation by diltiazem of arterial baroreflex sensitivity in man.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; F Lhoste; C Richer; C Thuillez; A Jacolot
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Effects of verapamil, diltiazem and ryosidine on the release of dopamine and acetylcholine in rabbit caudate nucleus slices.

Authors:  K Starke; L Späth; T Wichmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

6.  Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra.

Authors:  B Larsson; E D Högestätt; A Mattiasson; K E Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

7.  Effect of verapamil on the non-adrenergic response of the field stimulated rat vas deferens.

Authors:  V Raviprakash; S K Mishra; J N Panda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

8.  The effect of diltiazem on noradrenaline release.

Authors:  C Wolchinsky; T T Zsotér
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

9.  Cocaine-calcium channel antagonist interactions.

Authors:  M C Rowbotham; W D Hooker; J Mendelson; R T Jones
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine.

Authors:  Sm Aburawi; Ra Al-Tubuly; Ea Alghzewi; Zm Gorash
Journal:  Libyan J Med       Date:  2007-12-01       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.